Health In Tech Seeks Vote to Triple Authorized Shares to 720M and Expand SEPA Issuance
HIT is trading near its 52-week low of $0.65 (14% above the low).
Summary
Health In Tech's definitive proxy sets a November 10 vote on tripling authorized shares to 720M, expanding Yorkville SEPA issuance beyond the 19.99% cap, and adding 10M shares to its equity plan. The filing also discloses Nasdaq board independence and audit committee non-compliance.
Key Events · Corporate Governance and Compliance · HIT
-
Authorized Shares Triple to 720M
Proposal Two seeks to increase authorized Class A shares from 150M to 650M, plus 50M Class B and 20M Series A preferred — a total of 720M shares, up from 220M currently authorized.
-
SEPA Issuance Beyond 19.99% Cap
Proposal Three asks stockholders to approve Yorkville SEPA issuance beyond the 13,100,378-share exchange cap (19.99% of shares outstanding at signing). The SEPA allows up to $20M in advances at 97% of the lowest VWAP over three days, with a Minimum Price of $1.05 under Nasdaq rules.
-
Equity Plan Reserve Doubles
Proposal Four increases the 2024 Equity Incentive Plan reserve from 10,677,849 to 20,677,849 Class A shares — a 10M share increase that adds further dilution potential.
-
Nasdaq Governance Non-Compliance
The company discloses it is not in compliance with Nasdaq majority-independent board and three-member audit committee requirements after Sanjay Shrestha's August 10, 2026 resignation. Cure period expires February 6, 2027.
Analysis · HIT · Finance
The definitive proxy sets a November 10, 2026 vote on a package of highly dilutive proposals: tripling authorized Class A shares from 150M to 650M, approving Yorkville SEPA issuance beyond the 19.99% exchange cap, and adding 10M shares to the equity incentive plan. The company also discloses it is out of compliance with Nasdaq board independence and audit committee requirements following a director resignation, with a cure deadline of February 6, 2027. For a company with a $47M market cap and a stock near $0.74, the combined authorization represents massive potential dilution and signals continued reliance on equity-linked financing.
How filings like this one have moved
In the 30 days to Oct 27, 2026, 36.2% of the 898 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.75%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HIT was trading at $0.74 on NASDAQ in the Finance sector, with a market capitalization of approximately $47M. The 52-week trading range was $0.65 to $3.57. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.